Risk factors
Traws Pharma (TRAW) risk factors
Item 1A of every Traws Pharma, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors44 risks7 dropped6 reworded
Traws Pharma dropped merger-related integration risks following its past combination with Trawsfynydd. Financial disclosures updated to reflect net income of $9.2 million for 2025 due to warrant liability changes. Outstanding warrants and Series C preferred stock conversion figures were revised downwards.
Filed Apr 15, 2026 - FY2024 10-K risk factors51 risks
Substantial doubt exists regarding the company's ability to continue as a going concern with $21.3 million in cash against $11.5 million in current liabilities.
Filed Mar 31, 2025